<--- Back to Details
First PageDocument Content
Drug safety / Vaccination / Biotechnology / Preventive medicine / Vaccine court / Vaccine / National Center for Immunization and Respiratory Diseases / National Childhood Vaccine Injury Act / Health / Medicine / Prevention
Date: 2014-05-19 16:17:53
Drug safety
Vaccination
Biotechnology
Preventive medicine
Vaccine court
Vaccine
National Center for Immunization and Respiratory Diseases
National Childhood Vaccine Injury Act
Health
Medicine
Prevention

. Case Number: [removed]F · FOIA MARKER This is .not a textual record. This is used as an administrative marker by the Clinton Presidential

Add to Reading List

Source URL: www.clintonlibrary.gov

Download Document from Source Website

File Size: 278,97 KB

Share Document on Facebook

Similar Documents

Biotechnology, BS

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap:  Patenting Biotechnology In The European Community

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document